DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of COVID ...
A new analysis of clinical trial data indicates that psilocybin-assisted psychotherapy provides immediate relief for anxiety ...
The researchers also examined potential health risks linked to cannabis use. Long-term data from adolescents suggested that ...
In the CAPItello-291 trial of capivasertib plus fulvestrant, 73% of patients had already received a CDK4/6 inhibitor. As ...
Marijuana is prescribed to help ease chronic pain and control nausea in cancer patients, but legal red tape has made more ...
Combining a keto diet with intermittent fasting may help boost fat burning, energy, and blood sugar control, though it may ...
In modified intention-to-treat analysis, time to linkage to care significantly less for people with HIV in intervention group ...
Lipoic acid offers no improvements in walking speed or other outcomes in patients with progressive multiple sclerosis ...
Olema Pharmaceuticals (OLMA) earns a "Strong Buy" rating, driven by advancing palazestrant for 1st-line ER+/HER2- metastatic ...
Early results from a phase 2 clinical trial show that denifanstat for 12 weeks improved lesion counts in patients with acne vulgaris.
Self-hypnosis is an accessible, effective treatment for hot flashes, according to an expert. Gary Elkins, PhD, professor of ...
Radiation has been a staple of breast cancer treatment for decades, but a new study is casting doubt on whether it is ...